Growth Metrics

Bio-Techne (TECH) Equity Income (2023 - 2026)

Bio-Techne's quarterly Equity Income came in at -$739000.0 in Q1 2026, down 25.47% year-on-year from -$991505.7 in Q1 2025, and down 771.82% quarter-over-quarter from $110000.0 in Q4 2025.

Bio-Techne has reported Equity Income for 4 years, with the latest figure at -$739000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Income fell 25.47% year-over-year to -$739000.0; the trailing twelve-month figure through Mar 2026 stood at $772000.0 (up 172.83% YoY), and the FY2025 full-year result was $938000.0, up 113.71% from the prior year.
  • Equity Income for Q1 2026 stood at -$739000.0, down from $110000.0 in the prior quarter.
  • The five-year high for Equity Income was $1.1 million in Q2 2025, with the low at -$2.3 million in Q3 2023.
  • Average Equity Income over 4 years is -$567181.8, with a median of -$589000.0 recorded in 2025.
  • Year-over-year, Equity Income jumped 224.24% in 2025 and dropped 25.47% in 2026.
  • Tracing TECH's Equity Income over 4 years: stood at -$1.9 million in 2023, then soared by 102.4% to $46000.0 in 2024, then jumped by 139.13% to $110000.0 in 2025, then tumbled by 771.82% to -$739000.0 in 2026.
  • The last three Equity Income figures came in at -$739000.0 (Q1 2026), $110000.0 (Q4 2025), and $294000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 235,807.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn -739,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -739,000.00
Dec 31, 2025 110,000.00
Sep 30, 2025 294,000.00
Jun 30, 2025 1.11 Mn
Mar 31, 2025 -589,000.00
Dec 31, 2024 46,000.00
Sep 30, 2024 374,000.00
Jun 30, 2024 -891,000.00
Mar 31, 2024 -1.75 Mn
Dec 31, 2023 -1.91 Mn
Sep 30, 2023 -2.29 Mn